India’s Alembic Pharma opens anticancer manufacturing plant in Gujarat

Alembic Pharmaceuticals opens oncology manufacturing facility in India.

API drugmaker Alembic Pharmaceuticals is diving into the oncology arena by opening an anticancer manufacturing facility at Panelav, Halol, in Gujarat.

The company, best known for manufacturing anti-infective, analgesic and cough and cold therapies, said the facility will manufacture 60 million tablets and capsules and about 20 million vials of liquid injectable and lyophilized concentrates.

Chirayu Amin, chairman of Alembic, said the company expects to export oncology products to the U.S., Middle East, North Africa, Australia and South Africa. The facility boasts the latest manufacturing equipment from Germany, Belgium, the U.K., and China, he said.


Veeva 2020 Unified Clinical Operations Survey

We believe you have the knowledge and expertise to make this year's Veeva 2020 Clinical Operations Report even more robust and insightful than the last. Please take a moment to share your opinion in this 10-minute survey. All qualified respondents will be entered to win a $500 Amazon gift card.

Alembic managing director Pranav Amin said the company is looking to invest about $23 million as part of its expansion plan over the next three years, the Economic Times Healthworld reported.

Suggested Articles

Fujifilm says it is prepared to ramp up production of Avigan for any country that wants to try it as a potential treatment for COVID-19.

As flights from China contract and prices double, the logistics of getting products out of China is a major challenge. 

A group of drugmakers and others say some federal policies to fight COVID-19 are it making more expensive and harder to get some drugs.